Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen Spray for Postoperative Sore Throat Following Double-Lumen Endobronchial Intubation
NCT07163429Active, not recruiting
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of flurbiprofen in postoperative sore throat (POST) and hoarseness (2 arms). Primary endpoint: Incidence of Postoperative Sore Throat at 48 hours. Started Sep 2025; status: active, not recruiting.
02
Drugs
flurbiprofen
03
Conditions
postoperative sore throat (POST)hoarseness
Beyond the preview
Go deeper on NCT07163429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163429.